Francois Curtin
GeNeuro SA Chemin des Aulx 18 CH-1228 Plan-les-Ouates/Geneva,
Swaziland
Short Communication
Benefit-Risk of Immunomodulators in Multiple Sclerosis. Alemtuzumab and Next?
Author(s):